Le Lézard
Classified in: Health
Subjects: CHI, PDT, WOM

Lorestry Announces Maternal-Child Health - Mapping for Two


CONCORD, Mass., Aug. 5, 2022 /PRNewswire/ -- Lorestry, the world's first and only app that maps health data for parents to the language of healthcare, now captures mother-baby dyad stories during pregnancy. 

Lorestry, the world's first app to collect and map the social & environmental health drivers for the mother-baby dyad.

A free, next-generation app for a new generation of parents, Lorestry provides expecting parents with a meaningful and powerful health data asset that they curate and control. With Lorestry, it is parents ?? not health systems, payers, or providers, who determine who has access to their private  information. Parents can use their data set for informed conversations, relationship-building, sharing, collaboration, self-advocacy, and family health history creation.

Lorestry is the world's first and only app that maps data for health consumers to the language of healthcare. Follow @Lorestry on Twitter.

The expanded version of the app has been released at a critical period for maternal-child health.

Lorestry, the first app that collects and maps real-world data for consumers, includes daily tracking of maternal feelings, documentation of conditions that may be diagnosed in utero, and the social/environmental conditions that impact maternal-child outcomes. Access to air conditioning, as just one example, has a serious impact on maternal health and infant prematurity. In July 2021, the American College of Obstetrics and Gynecology (ACOG) released new clinical guidance about heat and environmental risks and highlighted "that climate change is an urgent women's health concern as well as a major public health challenge." Additionally, ACOG states that "There is emerging evidence that links exposure to toxic environmental agents and adverse reproductive and developmental health outcomes." 

Lorestry provides a way to capture social determinants of health (SDoH) and environmental determinants of health (EDoH) variables which can be shared with health systems, community health, and early education providers. Privately capturing this information in real-time and outside of the clinical setting, reduces geographical barriers, and should help accelerate time-sensitive interventions that have been shown to improve life outcomes. The app simultaneously creates a longitudinal record of early life experiences and developmental progression.

Lorestry is a top ranked pregnancy and baby app in 14 countries, and available on the App store.

Lorestry
Lorestry is the world's first and only app that maps data for health consumers to the language of healthcare and humankind. The free Lorestry app creates a private health data asset that is meaningful, useful, and readable (by humans and computers). Designed for use starting in pregnancy through age 6, Lorestry is the first app inclusive of all children, including those with special healthcare and record gathering needs. Follow @Lorestry on Twitter.

Alea Diagnostics
Alea Diagnostics, creator of the Lorestry app, provides family-friendly benefit solutions for employers to promote diversity, equity, and inclusion, and that support underserved populations. Alea works with hospitals and health systems interested in health equity for newborns and children. Follow @AleaDx on Twitter.

SOURCE Alea Diagnostics, Inc.


These press releases may also interest you

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...

at 17:31
DRI Healthcare Trust (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 warrants were...



News published on and distributed by: